Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday | 7 | Benzinga.com | ||
Fr | EXICURE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
EXICURE Aktie jetzt für 0€ handeln | |||||
Fr | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
10.06. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
28.05. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
28.05. | Exicure receives Nasdaq non-compliance notice for late quarterly filing | 1 | Seeking Alpha | ||
28.05. | Exicure faces Nasdaq non-compliance notice | 1 | Investing.com | ||
06.05. | EXICURE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
14.04. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
18.03. | EXICURE, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
18.03. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
13.03. | Pre-market Movers: Y-mAbs Therapeutics, Aveanna Healthcare, UiPath, Exicure, CareCloud | 629 | AFX News | SANTA CLARA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.55 A.M. ET).In the Green Aveanna Healthcare Holdings Inc. (AVAH) is up... ► Artikel lesen | |
05.03. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
21.02. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
23.01. | Exicure, back from brink and under new management, buys GPCR's US unit and clinical-stage drug | 2 | FierceBiotech | ||
23.01. | Exicure Buys GPCR USA From GPCR Therapeutics, Signs L&C Deal; Stock Climbs | 1 | RTTNews | ||
22.01. | EXICURE, INC. - 8-K, Current Report | - | SEC Filings | ||
06.01. | EXICURE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
27.12.24 | Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech | 210 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "Exicure", "the Company"), has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. ("GPCR Therapeutics")... ► Artikel lesen | |
20.12.24 | Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes | 302 | Business Wire | CHICAGO--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR, "the Company", "Exicure"), today announced that in connection with the change of control transaction approved by the stockholders at the Special... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
NOVARTIS | 103,12 | +0,21 % | Novartis Pharma AG: Novartis completes acquisition of Regulus Therapeutics | Basel, June 25, 2025 - Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. ("Regulus"). With the completion of the acquisition, shares of common... ► Artikel lesen | |
GILEAD SCIENCES | 94,21 | +0,14 % | Assembly Biosciences: ABI-4334 erreicht Studienziel - Gilead-Entscheidung steht bevor | Assembly Biosciences (WKN: A402CB) liefert weiter ab: Mit ABI-4334 fällt der erste wichtige Readout dieses Jahres positiv aus. Das HBV-Asset galt als das unsicherste im Portfolio. Die Aktie liebäugelt... ► Artikel lesen | |
AURORA CANNABIS | 3,630 | +0,97 % | Aurora Cannabis Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
CANOPY GROWTH | 1,058 | +2,72 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
ELI LILLY | 661,30 | -1,40 % | Eli Lilly | Rolls-Royce | VW - Rücksetzer bei Palantir ausnutzen? | Markus Weingran - Mein Tipp: SMARTBROKER+: https://dwbdiv.smartbrokerplus.de/ts/94450/tsc - typ=r&amc=con.smartbrokerplus.536232.548190.CRTuFopWREk&smc1=YouTube (Werbung) Willkommen bei der Börsenlounge... ► Artikel lesen | |
MERCK & CO | 67,30 | +0,15 % | Merck & Co.: Patente, Prognosen und eine fatale Fehleinschätzung | Auslaufende Patente, geopolitische Risiken, Abschreibungen. Merck steht unter Druck, doch abseits der Schlagzeilen läuft das Geschäft erstaunlich gut Den vollständigen Artikel lesen ... ► Artikel lesen | |
ASTRAZENECA | 118,65 | -1,17 % | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca mit einem Kursziel von 14000 Pence auf "Overweight" belassen. Die beschleunigte US-Zulassung von Datroway gegen... ► Artikel lesen | |
HALO COLLECTIVE | 0,010 | 0,00 % | Waters Corporation Buys Halo Labs | WASHINGTON (dpa-AFX) - Waters Corporation (WAT), an analytical instruments and software firm, said on Wednesday that it has acquired Halo Labs, a company focused on specialized imaging technologies... ► Artikel lesen | |
TILRAY BRANDS | 0,355 | +0,42 % | Tilray Brands, Inc.: Tilray Medical erhält vom italienischen Gesundheitsministerium die erste Genehmigung für den Vertrieb von medizinischen Cannabisblüten für therapeutische Zwecke | SAVONA, Italien, June 25, 2025 (GLOBE NEWSWIRE) -- Tilray Medical ("Tilray"), ein Geschäftsbereich von Tilray Brands, Inc. (NASDAQ: TLRY und TSX: TLRY) und weltweit führender Anbieter von medizinischem... ► Artikel lesen | |
INNOCAN PHARMA | 0,138 | -2,48 % | InnoCan Pharma: Mega-News im Anmarsch? | ||
TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | CSE Bulletin: Suspensions - Blender Bites Limited, TAAT Global Alternatives Inc. | Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2025) - Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as... ► Artikel lesen | |
ARZNEIWERK AG VIDA | 0,570 | -5,79 % | XETR DELETION OF INSTRUMENTS FROM XETRA - 30.06.2025 | The following instruments on XETRA do have their last trading day on 30.06.2025Die folgenden Instrumente auf XETRA haben ihren letzten Handelstag am 30.06.2025ISIN NameDE000A3EX3G0 GORE German Office... ► Artikel lesen | |
CRONOS GROUP | 1,590 | -2,21 % | Cronos Group Inc: Cronos shareholders elect seven directors at AGM | ||
EYEPOINT PHARMACEUTICALS | 8,416 | +5,31 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
IONIS PHARMACEUTICALS | 34,900 | +4,02 % | Barclays upgrades Ionis Pharmaceuticals stock to Overweight on Tryngolza outlook |